Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: Results of two phase II clinical trials

Christopher W. Ryan, Nicholas J. Vogelzang, Mary C. Dumas, Timothy Kuzel, Walter M. Stadler*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: Results of two phase II clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences